For: | Saif MW, Shi N, Zelt S. Capecitabine treatment patterns in patients with gastroesophageal cancer in the United States. World J Gastroenterol 2009; 15(35): 4415-4422 [PMID: 19764093 DOI: 10.3748/wjg.15.4415] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i35/4415.htm |
Number | Citing Articles |
1 |
Taekyu Lim, Jeeyun Lee, Duk Joo Lee, Ha Yeon Lee, Boram Han, Kyung Kee Baek, Hee Kyung Ahn, Su Jin Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Kyoung-Mee Kim, Won Ki Kang. Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer. Cancer Chemotherapy and Pharmacology 2011; 68(1): 255 doi: 10.1007/s00280-011-1653-5
|
2 |
Hongbo Yang, Andrew P. Yu, Eric Q. Wu, Yeun Mi Yim, Elaine Yu. Healthcare costs associated with bevacizumab and cetuximab in second-line treatment of metastatic colorectal cancer. Journal of Medical Economics 2011; 14(5): 542 doi: 10.3111/13696998.2011.596600
|
3 |
Aurore Palmaro, Martin Gauthier, Fabien Despas, Maryse Lapeyre‐Mestre. Identifying cancer drug regimens in French health insurance database: An application in multiple myeloma patients. Pharmacoepidemiology and Drug Safety 2017; 26(12): 1492 doi: 10.1002/pds.4266
|
4 |
Kathy L. Schulman, Karina Berenson, Ya-Chen (Tina) Shih, Kathleen A. Foley, Arijit Ganguli, Jonas de Souza, Nicholas A. Yaghmour, Alex Shteynshlyuger. A Checklist for Ascertaining Study Cohorts in Oncology Health Services Research Using Secondary Data: Report of the ISPOR Oncology Good Outcomes Research Practices Working Group. Value in Health 2013; 16(4): 655 doi: 10.1016/j.jval.2013.02.006
|
5 |
MUHAMMAD WASIF SAIF, LESLIE LEDBETTER, KRISTIN KALEY, MARIE CARMEL GARCON, TERESA RODRIGUEZ, KOSTAS N. SYRIGOS. Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma. Oncology Letters 2014; 8(3): 1302 doi: 10.3892/ol.2014.2238
|